Fourth Circuit Rejects FCA Case Against Omnicare

, The Litigation Daily

   | 0 Comments

The court held that even if the government paid for tainted drugs packaged by Omnicare, the company didn't violate the False Claims Act because the FDA had approved the unadulterated form of the drugs. The ruling is a win for Reed Smith.

What's being said

Comments are not moderated. To report offensive comments, click here.

Preparing comment abuse report for Article# 1202644083342

Thank you!

This article's comments will be reviewed.